Key result
Kawasaki disease is an acute inflammatory vasculitis of childhood and the most common cause of acquired cardiovascular disease in children in the US, managed primarily with IVIG and aspirin.
This review summarizes the pathophysiology, management, and long-term follow-up strategies for Kawasaki disease, highlighting its role as a leading cause of acquired pediatric cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Standard IVIG-aspirin therapy for Kawasaki disease is reaffirmed; leaves open optimization of long-term cardiovascular surveillance in children.
Kawasaki disease (KD) is an acute inflammatory vasculitis of childhood which was initially described more than 4 decades ago, yet the specific etiology remains unknown. It has become the most common cause of acquired cardiovascular disease in children in the United States. Advances in clinical therapies have reduced, but not eliminated, the incidence of coronary artery abnormalities in affected children. Pathophysiology seems to include an intense elaboration of cytokines, endothelin, and other vasoactive mediators resulting in the development of vascular endothelial changes that may leave a permanent impact on vascular integrity. Treatment with intravenous immune globulin and aspirin remains the primary management strategy and steroid therapy remains contoversial. In severe circumstances, coronary reperfusion strategies are required, and coronary artery surgery in children with KD has been required, albeit infrequently. KD may be a harbinger for early onset coronary artery disease in adults. Recently developed AHA recommendations have amended diagnostic strategies and indicated a stratified approach to the long-term follow up of this enigmatic yet widespread disease.
No takes yet. Share an insight, caveat, or question.
Satou et al. (2007) conducted a review in Kawasaki disease. Kawasaki disease is an acute inflammatory vasculitis of childhood and the most common cause of acquired cardiovascular disease in children in the US, managed primarily with IVIG and aspirin.
Synapse has enriched 10 related papers. Consider them for comparative context: